First-line HIV treatment outcomes following the introduction of integrase inhibitors in UK guidelines: a cohort study.
Kel Bouzidi, UK Chic Study, Mark Gompels, Ab Schaap(London School of Hygiene & Tropical Medicine), Anton Pozniak, Sophie José(NHS England), Caroline Sabin(Primary Health Care), Alan Winston(Imperial College London), Andrew Ustianowski(North Manchester General Hospital), AN Phillips(The Royal Free Hospital), DT Dunn
UCL Discovery (University College London)
June 8, 2020
Cited by 0
Related Papers
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
|AIDS|2003|987
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
|The Lancet|2014|930
Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV
|New England Journal of Medicine|2006|886